Central sleep apnea device increases mortality in heart failure

Adaptive servo-ventilation (ASV) therapy increases mortality and should not be used to treat central sleep apnea in heart failure patients with reduced ejection fraction, the SERVE-HF trial shows.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1Vu4FWK

No comments:

Post a Comment